Intranasal oestrogen cream for the prevention of epistaxis in patients with bleeding disorders.
Haemophilia (impact factor: 2.6). 01/2011; 17(1):164. DOI:10.1111/j.1365-2516.2010.02356.x pp.164
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.